Russell Investments Group
PETX

Russell Investments Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Russell Investments Group’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40,200
Closed -$144K – 3041
2019
Q1 		$144K Buy
40,200
+17,500
+77% +$75.8K ﹤0.01% 2675
2018
Q4 		$139K Buy
22,700
+9,400
+71% +$57.4K ﹤0.01% 2673
2018
Q3 		$78K Sell
13,300
-500
-4% -$2.5K ﹤0.01% 2788
2018
Q2 		$59K Buy
+13,800
New +$69.6K ﹤0.01% 2795

Other funds holding PETX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Russell Investments Group's PETX Position: Q2 2019 in Review

Russell Investments Group sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 40,200 shares — an estimated $144K sold.

Russell Investments Group first reported a position in PETX in Q2 2018 and held it in 4 quarters. The position peaked at $144K in Q1 2019. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

  • Russell Investments Group reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Russell Investments Group sold 40,200 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $144K.
  • Russell Investments Group first reported a position in Aratana Therapeutics, Inc. in Q2 2018 and held it in 4 quarters.
  • Russell Investments Group's Aratana Therapeutics, Inc. position peaked at $144K in Q1 2019.
  • 103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on Russell Investments Group's 13F filing for Q2 2019, filed 9 Aug 2019.